Recently, FURIN was suggested to be a potential biomarker of hypertension (He et al., 2019) and cancer (Zhou and Gao, 2021), reflecting the involvement of this broadly expressed proprotein convertase in many critical biological processes. This evidence concerns the gene FURIN and cancer.